Year of Award:
Molecular & Cellular Analysis Technologies
MUDDIMAN, DAVID C.
Other PI or Project Leader:
The development of biomarkers for earlier detection of ovarian cancer will greatly improve survival. Most women present with advanced stage disease with survival rates of roughly 20%. Advances in the field of proteomics now provide the tools necessary to